NEXI — Neximmune Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: NexImmune and Agents Agreed To Terminate Sales Agreement & ATM Program dated June 2022
Brief: NexImmune Says Co Expects Existing Cash And Cash Equivalents Will Be Sufficient To Meet Its Anticipated Cash Requirements Through Mid-February 2024
Brief: Neximmune Gets Notice From Listing Qualifications Department Of Nasdaq
Brief: NexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual Meeting
Brief: Neximmune Announces 1-For-25 Reverse Stock Split
Brief: Neximmune Announces Workforce Reduction To Enable Continued Aimtm Nanoparticle Platform Development Strategy
Brief: Neximmune Says Estimates To Incur About $2.3 Million Of Costs In Connection With Reduction In Workforce
Neximmune Inc reports results for the quarter ended in June - Earnings Summary
Brief: Neximmune Reports First Quarter 2023 Financial Results And Provides Business Updates
Neximmune Inc expected to post a loss of 46 cents a share - Earnings Preview
Brief: Neximmune - On April 25, Got Letter From Nasdaq That Co Has 180-Day Extension To October 23 To Regain Compliance With Minimum Bid Price Requirement
Brief: Neximmune Posts Q4 Loss Of $0.65 Per Share
Neximmune Inc reports results for the quarter ended in December - Earnings Summary
Neximmune Inc expected to post a loss of 53 cents a share - Earnings Preview
Brief: Neximmune Inc Does Not Hold Cash Deposits Or Securities At Silicon Valley Bank
Neximmune Inc expected to post a loss of 53 cents a share - Earnings Preview
Neximmune Inc reports results for the quarter ended in September - Earnings Summary
Brief: NexImmune Inc Says Co To Initiate Workforce Reduction Plan To Reduce Headcount By About 30%
Brief: NexImmune Reports Third Quarter 2022 Financial Results, Announces Strategic Update